Showing results (171-180 of 324) with videos related to
Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2017
Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen EncounterKrit Ritthipichai, Cara L Haymaker, Melisa Martinez, et al.Cancer|December 20, 2011
NRAS mutation status is an independent prognostic factor in metastatic melanomaJohn A Jakob, Roland L Bassett, Chaan S Ng, et al.The Journal of Biological Chemistry|August 21, 2010
2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1Roberto Carreño, Wells S Brown, Dan Li, et al.Cell|September 27, 2016
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyJianjun Gao, Lewis Zhichang Shi, Hao Zhao, et al.Journal for Immunotherapy of Cancer|July 26, 2022
CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signalingSamantha M Fix, Marie-Andrée Forget, Donastas Sakellariou-Thompson, et al.Biorxiv : the Preprint Server for Biology|August 1, 2026
Dual stimulation of CD40 and 41BB pathways during ex-vivo TIL expansion enhances CD8+ T cell expansionRenata Ariza Marques Rossetti, Matthew S Beatty, Junior Cianne, et al.Oncotarget|May 8, 2018
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutationsNeeta Somaiah, Hannah C Beird, Andrea Barbo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.American Journal of Clinical Oncology|March 7, 2018
Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the LiverJesus Vera-Aguilera, Agop Y Bedikian, Roland L Bassett, et al.Human Gene Therapy|June 14, 2003
Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigenSteven A Rosenberg, James C Yang, Richard M Sherry, et al.Pageof 33